Published in J Clin Invest on January 01, 1975
Defective in vitro production of gamma-interferon and tumor necrosis factor-alpha by circulating T cells from patients with the hyper-immunoglobulin E syndrome. J Clin Invest (1989) 1.55
Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses. Clin Exp Immunol (1987) 1.14
Immunoglobulin systems of human tonsils. II. Patients with chronic tonsillitis or tonsillar hyperplasia: quantification of Ig-producing cells, tonsillar morphometry and serum Ig concentrations. Clin Exp Immunol (1978) 1.12
New insights into the enigma of immunoglobulin D. Immunol Rev (2010) 1.06
IgM and IgD concentrations in the serum and secretions of children with selective IgA deficiency. Clin Exp Immunol (1983) 1.03
Increased serum IgD concentrations in patients with Hodgkin's disease. Clin Exp Immunol (1977) 0.99
An in vitro model of allergen-dependent IgE synthesis by human B lymphocytes: comparison of the response of an atopic and a non-atopic individual to Dermatophagoides spp. (house dust mite). Immunology (1989) 0.98
T-cell depletion and in vitro thymosin inducibility in asthmatic children. Clin Exp Immunol (1978) 0.98
In vitro synthesis of IgE by human peripheral blood leucocytes: relationship to serum titre of leucocyte donor. Clin Exp Immunol (1981) 0.96
Variability in B cell maturation and differentiation in X-linked agammaglobulinemia. Clin Exp Immunol (1986) 0.94
Jejunal bacterial overgrowth and intestinal permeability in children with immunodeficiency syndromes. Gut (1990) 0.93
Immunoglobulin levels in white and metis communities in Saskatchewan. Clin Exp Immunol (1977) 0.89
The relationship between atopy and salivary IgA deficiency in infancy. Clin Exp Immunol (1985) 0.89
The metabolism of IgE in patients with immunodeficiency states and neoplastic conditions. J Clin Invest (1977) 0.84
Immunological investigations in individuals with selective IgA deficiency. Clin Exp Immunol (1986) 0.82
Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients. Proteomics Clin Appl (2014) 0.82
Immunoglobulin D: properties, measurement, and clinical relevance. Clin Diagn Lab Immunol (2000) 0.82
IgE Fc receptor positive T and B lymphocytes in patients with the hyper IgE syndrome. Clin Exp Immunol (1985) 0.81
The [HLA-B18, F1C30, DR3] conserved extended haplotype carries a susceptibility gene for IgD deficiency. J Clin Immunol (2000) 0.81
Serum immunoglobulins G, A, M, D and E concentrations in lymphomas. Br J Cancer (1979) 0.80
Antisera to human IgE can also recognize IgA and IgM molecules as produced by selected B lymphoblastoid cell lines. Clin Exp Immunol (1988) 0.77
Transient increase of serum IgD levels after allogeneic bone-marrow transplantation. Clin Exp Immunol (1988) 0.75
Diagnosis of allergy. Br Med J (1977) 0.75
Light chain types of IgD in human bone marrow and serum. Clin Exp Immunol (1985) 0.75
Increase in peripheral blood 'null' cells in extrinsic bronchial asthma. Clin Exp Immunol (1977) 0.75
IgA and IgM protein primarily drive plasma corona-induced adhesion reduction of PLGA nanoparticles in human blood flow. Bioeng Transl Med (2017) 0.75
Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature (1962) 64.93
Immunoglobulin D as a lymphocyte receptor. J Exp Med (1973) 4.62
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75
Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics (1971) 3.69
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol (1971) 3.48
Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47
A NEW CLASS OF HUMAN IMMUNOGLOBULINS. I. A UNIQUE MYELOMA PROTEIN. J Exp Med (1965) 3.42
A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD. J Exp Med (1965) 3.31
Regulation of homocytotropic antibody formation in the rat. 3. Effect of thymectomy and splenectomy. J Immunol (1971) 2.61
Surface-bound immunoglobulin on lymphocytes from normal and immunodeficient humans. Scand J Immunol (1972) 2.31
IgD on the surface of peripheral blood lymphocytes of the human newborn. Nat New Biol (1973) 2.19
Communications. IgD-bearing human lymphocytes. J Immunol (1972) 2.17
Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics (1968) 2.06
Standardization and stability of immunoglobulin E (IgE). J Allergy Clin Immunol (1972) 1.94
Regulation of homocytotropic antibody formation in the rat. II. Effect of X-irradiation. J Immunol (1971) 1.65
Biological function of gamma E antibodies and mechanisms of reaginic hypersensitivity. Clin Exp Immunol (1970) 1.56
Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. Acta Pathol Microbiol Scand (1968) 1.51
Metabolism of human immunoglobulin D (IgD). J Clin Invest (1966) 1.46
Immunoglobulin E deficiency in ataxia-telangiectasia. N Engl J Med (1969) 1.42
Immunoglobulin levels during childhood, with special regard to IgE. Acta Paediatr Scand (1969) 1.36
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
Immunoglobulin D in serum, body fluids and lymphoid tissues. Clin Exp Immunol (1968) 1.34
Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia. J Clin Invest (1972) 1.31
Studies on human IgD. II. The lack of skin sensitizing and complement fixing activities of immunoglobulin D. Immunochemistry (1969) 1.20
AN ANTIBODY DEFICIENCY SYNDROME. SELECTIVE IMMUNOGLOBULIN DEFICIENCY WITH REDUCED SYNTHESIS OF GAMMA AND ALPHA IMMUNOGLOBULIN POLYPEPTIDE CHAINS. Am J Med (1965) 1.13
Evaluation of T lymphocyte effector function in immunodeficiency diseases: abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. J Immunol (1974) 1.13
IgD antibody to insuin. Lancet (1970) 1.12
Regulation of homocytotropic antibody formation in the rat. IV. Effects of various immunosuppressive drugs. J Immunol (1971) 1.10
Serum IgE in clinical immunology and allergy. J Allergy Clin Immunol (1972) 1.08
Characterization of precipitating antibodies to ruminant serum and milk proteins in humans with selective IgA deficiency. N Engl J Med (1971) 1.07
Auto-antibodies of the IgD class. Clin Exp Immunol (1970) 1.06
Serum IgE concentrations in hypogammaglobulinaemia and selective IgA deficiency. Studies on patients and family members. Clin Exp Immunol (1972) 1.04
Antigen combining activity associated with immunoglobulin D. Science (1969) 1.04
Measurement of serum IgE by a one-step single radial radiodiffusion method. J Allergy Clin Immunol (1972) 1.03
Serum IgD concentrations in sarcoidosis and tuberculosis. Clin Exp Immunol (1972) 1.00
Serum IgE concentrations and skin reactivity to anti-IgE antibody in IgA-deficient patients. N Engl J Med (1971) 0.98
Healthy IgE-deficient person. N Engl J Med (1970) 0.97
Quantitative comparison of immunoglobulins in atopic (reaginic) and nonatopic (nonreaginic) individuals: higher gamma-D levels in atopic sera. J Allergy (1967) 0.96
IgE in immunodeficiency. Am J Pathol (1972) 0.95
Wiskott-Aldrich syndrome. A study of 6 cases with determination of the immunoglobulins A, D, G, M and ND. Acta Paediatr Scand (1968) 0.95
A study of antibody responses by radioimmunodiffusion with demonstration of gamma D antigen-binding activity in four sera. J Immunol (1970) 0.94
Thymic alymphoplasia with hyper-IgE-globulinemia. Pediatrics (1973) 0.92
Lack of skin-sensitizing property of gamma D myeloma protein in guinea pigs. J Immunol (1969) 0.88
Serum IgE in immune deficiency disorders. Clin Exp Immunol (1974) 0.79
Structure and biologic functions of human IgD. II. Alteration of serum IgD levels during pregnancy. Proc Soc Exp Biol Med (1973) 0.77
Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) (2000) 7.17
Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. AIDSCAP Malawi Research Group. Lancet (1997) 6.34
Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS (2000) 4.91
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (2001) 4.76
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet (1998) 4.32
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics (1972) 3.75
High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa. J Infect Dis (1998) 3.46
Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS (1997) 3.42
Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science (1995) 3.15
Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63
Sexual transmission of HIV: infectiousness and prevention. AIDS (1999) 2.59
Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS (1997) 2.51
Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med (1981) 2.31
Correlation of milk precipitins with IgA deficiency. N Engl J Med (1969) 2.28
Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med (1999) 2.25
Abnormalities in the regulation of human IgE synthesis. Immunol Rev (1978) 2.14
Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol (2000) 2.13
Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: comparison of NASBA with Amplicor reverse transcription-PCR amplification and correlation with quantitative culture. J Virol Methods (1996) 2.12
Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol (1986) 2.11
Mutations in the mu heavy-chain gene in patients with agammaglobulinemia. N Engl J Med (1996) 2.10
HIV in body fluids during primary HIV infection: implications for pathogenesis, treatment and public health. AIDS (2001) 2.08
Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy. Pediatrics (1968) 2.06
Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol (1997) 2.04
Human IgE biosynthesis in vitro: studies with atopic and normal blood mononuclear cells and subpopulations. J Immunol (1979) 2.03
Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol (2007) 2.03
Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol (1996) 1.94
Complete DiGeorge syndrome: persistence of profound immunodeficiency. J Pediatr (1998) 1.90
Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J Clin Microbiol (1994) 1.85
Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med (1977) 1.85
Expression of the gene defect in X-linked agammaglobulinemia. N Engl J Med (1986) 1.80
The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration. AIDS (1999) 1.76
Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med (1987) 1.75
Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol (1968) 1.70
Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases. Mol Cell (2001) 1.61
Quantitation of human immunodeficiency virus type 1 RNA in different biological compartments. J Clin Microbiol (2000) 1.60
Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS (1998) 1.59
Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. N Engl J Med (1986) 1.53
Transient hypogammaglobulinemia of infancy: review of the literature, clinical and immunologic features of 11 new cases, and long-term follow-up. J Pediatr (1978) 1.46
Association of CD4 cell depletion and elevated blood and seminal plasma human immunodeficiency virus type 1 (HIV-1) RNA concentrations with genital ulcer disease in HIV-1-infected men in Malawi. J Infect Dis (1998) 1.42
Clinical and immunologic features of selective IgA deficiency. Birth Defects Orig Artic Ser (1975) 1.39
Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS (1994) 1.38
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Natural killing in immunodeficient patients. J Immunol (1978) 1.37
Depression of cell-mediated immunity in atopic eczema. J Allergy Clin Immunol (1975) 1.37
Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol (1974) 1.35
Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency. Blood (1992) 1.34
Blocking of autologous and homologous leukocyte responses by human alloimmune plasmas: a possible in vitro correlate of enhancement. J Immunol (1972) 1.33
Comparison of NucliSens and Roche Monitor assays for quantitation of levels of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (1999) 1.32
Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden. J Infect Dis (1999) 1.32
Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med (2000) 1.31
Precipitins to Candida albicans in chronic mucocutaneous candidiasis studied by crossed immunoelectrophoresis with intermediate gel. Correlation with clinical and immunological findings. Clin Exp Immunol (1974) 1.28
HIV-1 viral load in blood, semen and saliva. AIDS (1997) 1.27
Antigenic comparison of feline coronavirus isolates: evidence for markedly different peplomer glycoproteins. J Virol (1987) 1.25
Molecular form of adenosine deaminase in severe combined immunodeficiency. Biochem Biophys Res Commun (1974) 1.24
Human IgE synthesis in vitro: a reassessment. J Immunol (1981) 1.24
Elevated IgA concentration in milk produced by mothers delivered of preterm infants. J Pediatr (1981) 1.22
Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies. J Clin Immunol (1987) 1.20
Heterogeneity of lymphocyte subpopulations in severe combined immunodeficiency. Evidence against a stem cell defect. J Clin Invest (1976) 1.18
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med (2001) 1.18
Assessing inheritance of agammaglobulinemia. N Engl J Med (1994) 1.15
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol (1982) 1.14
Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi. AIDS Res Hum Retroviruses (2005) 1.14
Adenosine deaminase and purine nucleoside phosphorylase deficiencies: evaluation of therapeutic interventions in eight patients. J Clin Immunol (1987) 1.12
Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency. Blood (1997) 1.12
Recombinant human IL-4 induces IgE and IgG synthesis by normal and atopic donor mononuclear cells. Similar dose response, time course, requirement for T cells, and effect of pokeweed mitogen. J Immunol (1990) 1.12
Antibody-dependent cellular cytotoxicity in primary immunodeficiency diseases and with normal leukocyte subpopulations. Importance of the type of target. J Clin Invest (1978) 1.11
The effects of protease inhibitor therapy on human immunodeficiency virus type 1 levels in semen (AIDS clinical trials group protocol 850). J Infect Dis (2000) 1.11
Use of a human plaque-forming cell assay to study peripheral blood bursa-equivalent cell activation and excessive suppressor cell activity in humoral immunodeficiency. J Clin Invest (1979) 1.11
Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%). Vox Sang (2003) 1.10
Serum immunogbulin cocentrations during normal pregnancy. Am J Obstet Gynecol (1971) 1.09
Characterization of precipitating antibodies to ruminant serum and milk proteins in humans with selective IgA deficiency. N Engl J Med (1971) 1.07
Vertical transmission of multidrug-resistant human immunodeficiency virus type 1 (HIV-1) and continued evolution of drug resistance in an HIV-1-infected infant. J Infect Dis (2001) 1.06
Loss of infectivity ex vivo in plasma of human immunodeficiency virus-infected patients correlates with a high CD4 cell count. J Infect Dis (1993) 1.06
Hyper IgM syndrome associated with defective CD40-mediated B cell activation. J Clin Invest (1994) 1.05
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis (1998) 1.04
Hereditary alterations in the immune response: coexistence of "agammaglobulinemia", acquired hypogammaglobulinemia and selective immunoglobulin deficiency in a sibship. Pediatr Res (1968) 1.01
Serum immunoglobulins. 3. Abnormalities associated with chronic urticaria in children. J Allergy (1967) 1.01
Two phases of HIV RNA decay in CSF during initial days of multidrug therapy. Neurology (2003) 1.00
Antibody responses to protein, polysaccharide, and phi X174 antigens in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. J Allergy Clin Immunol (1991) 0.99
Correction of severe combined immunodeficiency by fetal liver cells. N Engl J Med (1976) 0.99
Inability of gestational hormones to account for the inhibitory effects of pregnancy plasmas on lymphocyte responses in vitro. Cell Immunol (1975) 0.99
X-linked severe combined immunodeficiency. Diagnosis in males with sporadic severe combined immunodeficiency and clarification of clinical findings. J Clin Invest (1990) 0.98
Oral and systemic factors associated with increased levels of human immunodeficiency virus type 1 RNA in saliva. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2000) 0.98
Serum IgE concentrations and skin reactivity to anti-IgE antibody in IgA-deficient patients. N Engl J Med (1971) 0.98
Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med (1990) 0.95
Competitive enzyme immunoassays for the rapid detection of antibodies to feline infectious peritonitis virus polypeptides. J Clin Microbiol (1985) 0.95
Lymphocyte responses to purified ragweed allergens in vitro. I. Proliferative responses in normal, newborn, agammaglobulinemic, and atopic subjects. J Allergy Clin Immunol (1977) 0.94
Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol (2001) 0.93
Identification of a deletion in the adenosine deaminase gene in a child with severe combined immunodeficiency. J Immunol (1987) 0.93
Sensitive method for the detection of infectious HIV in semen of seropositive individuals. J Virol Methods (1996) 0.93
Mononuclear cells from patients with the hyper-IgE syndrome produce little IgE when they are stimulated with recombinant human interleukin-4. J Allergy Clin Immunol (1991) 0.93
Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. J Pediatr (1996) 0.92
Severe combined immunodeficiency with leukopenia (reticular dysgenesis) in siblings: immunologic and histopathologic findings. J Pediatr (1976) 0.92
Multicenter crossover comparison of the safety and efficacy of Intraglobin-F with Gamimune-N, Sandoglobulin, and Gammagard in patients with primary immunodeficiency diseases. J Clin Immunol (1997) 0.91
Long-term outcome of non-ablative booster BMT in patients with SCID. Bone Marrow Transplant (2013) 0.91
Effects of reverse transcriptase inhibitor therapy on the HIV-1 viral burden in semen. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.91
Safety and patient acceptability of intravenous immune globulin in 10% maltose. Lancet (1980) 0.91
Abnormalities of leukotaxis in atopic dermatitis. J Allergy Clin Immunol (1977) 0.91